Cargando…
Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer
Pre-existing neutralizing antibody (NAb) against adeno-associated virus (AAV) commonly found in primates is a major host barrier that can severely compromise in vivo gene transfer by AAV vectors. To achieve proof-of-concept success in clinical development of recombinant AAV (rAAV)-based in vivo gene...
Autores principales: | Wang, Dan, Zhong, Li, Li, Mengxin, Li, Jia, Tran, Karen, Ren, Lingzhi, He, Ran, Xie, Jun, Moser, Richard P., Fraser, Cara, Kuchel, Tim, Sena-Esteves, Miguel, Flotte, Terence R., Aronin, Neil, Gao, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205343/ https://www.ncbi.nlm.nih.gov/pubmed/30397628 http://dx.doi.org/10.1016/j.omtm.2018.09.003 |
Ejemplares similares
-
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023) -
Size does matter: overcoming the adeno-associated virus packaging limit
por: Flotte, Terence R
Publicado: (2000) -
Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus
por: Tang, Qiushi, et al.
Publicado: (2020) -
Reduced Immunogenicity of Intraparenchymal Delivery of Adeno-Associated Virus Serotype 2 Vectors: Brief Overview
por: Hwu, Wuh-Liang, et al.
Publicado: (2022) -
Intraparenchymal Meningioma
por: Ramirez-Grueso, Raul, et al.
Publicado: (2021)